Altamira Therapeutics spins off part of its Bentrio business
In a strategic move to reposition its focus on its core RNA delivery technology, Altamira Technologies has sold a majority...
Read moreIn a strategic move to reposition its focus on its core RNA delivery technology, Altamira Technologies has sold a majority...
Read moreETH Zurich spin-off Alivion has secured CHF 3.8 million in funding to develop and test its next breath analysis device...
Read moreChildren’s Health Foundation co-funded projects include research by Melinda Halasz of University College Dublin and Cormac Owens of Children’s Health...
Read moreThe USD/CHF tested territory on both the low and high sides before settling into the midrange near 0.8840 on Wednesday,...
Read moreBoehringer Ingelheim has acquired University of Basel spinout T3 Pharmaceuticals for 450 million CHF ($507.4 million) in an effort to...
Read moreT3 Pharma spun out of the Biozentrum life sciences institute of the University of Basel in 2015 and has completed...
Read moreThe EUR should benefit from the fact that market expectations regarding interest rate cuts in the Eurozone are likely to...
Read moreThe UCI has quietly published updated regulations for clothing, feeding and other minor infringements, with non-compliant clothing, such as socks...
Read moreOn November 21, 2023 Issuer Switzerland issued bonds (CH1145908252) in the amount of CHF 690 mln maturing in 2024. The...
Read moreUSD/CHF snaps a three-day losing streak, edging higher near 0.8860 during the European session on Wednesday. The nine-day Exponential Moving...
Read more